CONMED Corp. buy Needham & Company LLC
Start price
01.02.24
/
50%
€77.50
Target price
01.02.25
€119.25
Performance (%)
-10.97%
End price
02.02.25
€69.00
Summary
This prediction ended on 02.02.25 with a price of €69.00. The prediction for CONMED Corp. disappointed with a performance of -10.97%. Needham___Company_LL has a follow-up prediction for CONMED Corp. where he still thinks CONMED Corp. is a Buy. Dividends of €0.74 are taken into consideration when calculating the performance. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CONMED Corp. | 3.191% | 3.191% | -34.237% |
| iShares Core DAX® | 0,05 % | 1,31 % | 11,38 % |
| iShares Nasdaq 100 | 1,60 % | -0,90 % | 7,29 % |
| iShares Nikkei 225® | 3,06 % | 12,95 % | 33,77 % |
| iShares S&P 500 | 0,82 % | 0,70 % | 4,93 % |
Comments by Needham___Company_LL for this prediction
In the thread CONMED Corp. diskutieren
CONMED Co. (NYSE: CNMD) had its price target raised by analysts at Needham & Company LLC from $119.00 to $129.00. They now have a "buy" rating on the stock.
Ratings data for CNMD provided by MarketBeat
In the thread Trading CONMED Corp.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten